Prashanth Anumandla
Acute Care · Houston, TXNPI 1831208966
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,128 of the $11,629 with a category attached, or 87.1%. 25 manufacturers reported payments, led by Abbott at 37.0% of the total. Among acute care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $50.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Cvrx, Inc.$2K
- Impulse Dynamics (USA) Inc.$1K
- Actelion Pharmaceuticals US, Inc.$1K
- Amgen$615
- Alnylam Pharmaceuticals Inc.$390
- plus $2K from 19 others
What the payments were for
- Travel & lodging$1,50013%
- Food & beverage$10,12887%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 105 | $4,307 |
| Cvrx, Inc. | 12 | $1,678 |
| Impulse Dynamics (USA) Inc. | 17 | $1,422 |
| Actelion Pharmaceuticals US, Inc. | 22 | $1,310 |
| Amgen | 19 | $615 |
| Alnylam Pharmaceuticals Inc. | 12 | $390 |
| AstraZeneca | 4 | $240 |
| Abiomed | 2 | $233 |
| Boehringer Ingelheim | 8 | $191 |
| ZOLL Respicardia, Inc. | 1 | $179 |
| Bayer | 4 | $174 |
| One Lambda, Inc. | 1 | $168 |
| Bridgebio Pharma, Inc. | 4 | $138 |
| Daiichi Sankyo Inc. | 2 | $134 |
| Merck | 1 | $83 |
| Pfizer | 4 | $69 |
| Novartis | 2 | $57 |
| Medtronic | 2 | $54 |
| AbbVie | 2 | $53 |
| Lantheus Medical Imaging, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$1,418
- Barostim Neo System$1,276
- OPTIMIZER$1,258
- UPTRAVI$746
- OPSUMIT$746
- CARDIOMEMS$536
- OPTIMIZER SMART SYSTEM$315
- Repatha$249
- Impella$233
- CardioMEMS HF System$181
- remede System$179
- INJECTAFER$110
- AMVUTTRA$109
How this compares
$11,629 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 14 | $338 |
Paid to pharmacies, not to this prescriber.
Other acute care in Houston
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Michelle JohnstonHouston$18K
- Amanda BergeronHouston$12K
- Nicole OnaHouston$12K
- Ken ChanHouston$11K
- Brittney RichardHouston$11K
- Antonio Paolo AlmacenHouston$11K
- Laura WuesteHouston$11K
- Jean UyHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.